Febrile neutropenia (FN) is a common dose-limiting toxicity of chemotherapy, with a
profound impact on the evolution of patients with cancer, due to the potential development of …

Febrile neutropenia (FN) is a common but serious complication encountered in patients with
cancer and is associated with significant morbidity and mortality. In this prospective study, 63 …

Cancer patients are a vulnerable group exposed to numerous and serious risks beyond
cancer itself. In recent years, the prognosis of these individuals has improved substantially …

Since its publication more than 15 years ago, the MASCC score has been internationally
validated any number of times and recommended by most clinical practice guidelines for the …

Background and Objectives: Risk stratification tools for febrile neutropenia exist but are
infrequently utilized by emergency physicians. Procalcitonin may provide emergency …

Background: Febrile neutropenia (FN) is an oncologic emergency which commonly occurrs
in patients who undergo chemotherapy, with a mortality rate of 12.5%. Risk stratification in …

The primary role of the oncology nurse practitioner in an acute tertiary cancer hospital in
Australia is to provide comprehensive symptom management to adult patients undergoing …

Amaç-hipotez: Nötropenik ateş miyelosupresif tedavinin mortalite, morbidite ve yüksek
tedavi maliyetleriyle ilişkili bir yan etkisidir. Hastaların komplikasyon gelişimi açısından …

Pendahuluan. Kondisi neutropenia meningkatkan risiko terjadinya infeksi. Penyebab
neutropenia banyak dibahas sebagai efek samping kemoterapi, namun pasien demam …

Le médecin traitant, par son rôle de médecin ambulatoire et médecin de famille, doit être un
intervenant privilégié dans le suivi du patient atteint de cancer. Il doit présenter un apport …